Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Automated AI-Based Aortic Measurements From Attenuation Correction CT as an Adjunctive Cardiovascular Risk Biomarker: An International Multicenter Study
Marcinkiewicz, Anna M , Shanbhag, Aakash , Chareonthaitawee, Panithaya , Zhang, Wenhao, Jilaihawi, Hasan , Zaid, Ryan , Cadet, Sebastien , Ramirez, Giselle , Lemley, Mark , Yi, Jirong , Hijazi, Waseem , Liang, Joanna X. , Fehér, Attila , Mason, Steve, Alexanderson, Erick, Carvajal-Juarez, Isabel , Travin, Mark I. , Rosamond, Thomas, Wopperer, Samuel , Berman, Daniel S. , Carli, Marcelo F. Di , Al-Jilaihawi, Hasanian , Builoff, Valerie , Calsavara, Vinicius F , Einstein, Andrew Jeffrey , Miller, Edward J , Feher, Attila , Ruddy, Terrence D , Le, Viet T , Knight, Stacey , Carvajal-Juarez, Isabel , Slipczuk, Leandro , Rosamond, Thomas L , Wopperer, Samuel , Berman, Daniel , Dey, Damini , Di Carli, Marcelo F , Miller, Robert J H , Slomka, Piotr J , Chareonthaitawee, Panithaya , Lemley, Mark , Ramirez, Giselle , Shanbhag, Aakash , Zaid, Ryan , Miller, Edward J. , Le, Viet T. , Mason, Steve, Knight, Stacey , Alexanderson, Erick , Slipczuk, Leandro , Dey, Damini , Miller, Robert J.H.

Circulation: Cardiovascular Imaging | July 2, 2026 | Volume: 19 | Issue: 7 | Pages: No page available

10.1161/circimaging.125.019726 | PMID 42389791 Get It

BACKGROUND: Aortic enlargement is a powerful predictor of dissection and rupture, yet it is rarely evaluated during routine myocardial perfusion imaging, despite the widespread availability of computed tomography (CT) attenuation correction scans. The aim of this study was to determine whether fully automated, opportunistically derived, artificial intelligence-based aortic measurements from myocardial perfusion imaging CT attenuation correction scans are associated with adverse outcomes in a large multicenter cohort. METHODS: CT attenuation correction scans from patients undergoing positron emission tomography/CT and single-photon emission CT/CT myocardial perfusion imaging across 10 centers were included. A deep learning model automatically segmented the thoracic aorta, and a postprocessing algorithm extracted maximum ascending and descending diameters. The aortic size index was calculated by indexing the diameter to body surface area. RESULTS: A total of 29 339 patients (56% men; median age, 66 years [interquartile range, 58–75 years]) were included. Over a median follow-up of 3.5 years (interquartile range, 1.9–5.0 years), 5083 (17.3%) patients died. Median ascending and descending aortic size index values were 1.8 cm/m 2 (interquartile range, 1.6–2.0) and 1.5 cm/m 2 (interquartile range, 1.4–1.6), respectively, with an increase with age and higher values in females. Elevated aortic size index thresholds (ascending >2.2 cm/m 2 ; descending >1.6 cm/m 2 ) were significantly associated with increased all-cause mortality (ascending: adjusted hazard ratio, 1.16 [95% CI, 1.07–1.26], P <0.001; descending: adjusted hazard ratio, 1.23 [95% CI, 1.14–1.31]; P <0.001). Notably, the prognostic value of an abnormal aortic size index persisted independent of age, sex, and perfusion abnormalities. CONCLUSIONS: Artificial intelligence can unlock previously unused information within routine myocardial perfusion imaging CT attenuation correction scans by rapidly and automatically quantifying aortic size at scale. Opportunistic aortic measurements derived from CT attenuation correction may serve as an adjunctive risk biomarker and could add prognostic value to standard myocardial perfusion imaging without additional imaging or radiation.
Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy
Testani, Jeffrey M. , Judge, Daniel P. , Borlaug, Barry A. , Cherney, David Z.I. , Gillmore, Julian D. , Lewis, Julia B. , Adler, Scott, Cao, Xiaofan , Castaño, Adam , Fox, Jonathan C. , Katz, Leonid , Mathur, V, Xiong, Kuangnan, Masri, Ahmad , Cherney, David , Cox, Zachary L , Gillmore, Julian D , Lewis, Julia B , Adler, Scott H , Cao, Xiaofan , Castaño, Adam , Fox, Jonathan C , Xiong, Kuangnan , Butler, Javed , Masri, Ahmad , Borlaug, Barry A , Testani, Jeffrey M , Judge, Daniel P , Mathur, Vandana S. , Butler, Javed

Circulation: Heart Failure | July 2, 2026 | Volume: 19 | Issue: 8 | Pages: No page available

10.1161/circheartfailure.126.014656 | PMID 42389794 Get It

BACKGROUND: Acoramidis achieves near-complete (≥90%) transthyretin stabilization and is approved to reduce cardiovascular-related mortality and hospitalization in transthyretin amyloid cardiomyopathy. Its effects on kidney function are not well characterized. METHODS: Data from randomized phase 2 (N=49) and phase 3 (N=632) studies in transthyretin amyloid cardiomyopathy were included. The estimated glomerular filtration rate (eGFR) slope was generated using a linear spline mixed-effects model. The urinary albumin-to-creatinine ratio was measured longitudinally. Relationships between changes in kidney function and clinical outcomes were explored using Cox proportional hazards models. RESULTS: Acoramidis initiation resulted in a modest acute dip in eGFR that was dose-dependent, reversible, and not associated with adverse kidney-related events. At Day 28, the mean (±SE) dip in eGFR from baseline with acoramidis was 8.5±0.48 mL/min per 1.73 m 2 ; the placebo-corrected reduction in the urinary albumin-to-creatinine ratio was 15.5% (95% CI, 0.4%–28.4%; P =0.044). The rate of decline in kidney function (chronic eGFR slope) was significantly improved with acoramidis versus placebo (−1.01 versus −3.48 mL/min per 1.73 m 2 per year; P <0.001), and the reduction in the urinary albumin-to-creatinine ratio was sustained (13.7% [95% CI, 1.7%–24.2%]; P =0.026) over time. Concomitant tafamidis use did not influence the chronic eGFR slope in either arm. Comparing acoramidis versus placebo subgroups with acute eGFR dips ≥ the median (4.89 mL/min per 1.73 m 2 ) favored acoramidis for all-cause mortality or cardiovascular-related hospitalization (hazard ratio, 0.42 [95% CI, 0.22–0.78]; P =0.006; P interaction=0.043) and cardiovascular-related hospitalization (hazard ratio, 0.34 [95% CI, 0.17–0.66]; P =0.002, P interaction=0.025). Within the placebo arm, eGFR dips portended worse outcomes. CONCLUSIONS: Acoramidis initiation resulted in an acute dip in eGFR and reductions in both the chronic eGFR slope and urinary albumin-to-creatinine ratio versus placebo without adverse kidney-related events. Acoramidis effects on kidney function may be mediated through direct kidney-protective hemodynamic effects. Importantly, the acute dip in eGFR was associated with a reduced risk of adverse clinical outcomes within the first year. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifiers: NCT03458130, NCT03536767, NCT03860935, NCT04988386.
Counterfactual Dermatology With Generative Models
Bahari, Rose , Goldust, Mohamad , Aristizabal Torres, Miguel A, Goldust, Mohamad , Aristizabal, Miguel

International Journal of Dermatology | July 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/ijd.70567 | PMID 42387814 Get It

Caregiver Reports of Lucid Episodes in Alzheimer’s Dementia and Lewy Body Dementias
Bangerter, Lauren R. , Kim, Kyungmin , Liu, Yin, Radford, Jonathan Graff, Liu, Yin, Lapid, Maria I. , Griffin, Joan M. , Kim, Kyungmin

Journal of Geriatric Psychiatry and Neurology | July 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/08919887261464594 | PMID 42387273 Get It

Purpose of Research Lucidity is the transient recovery of abilities and communication that were seemingly lost among people living with dementia (PLWD). This study describes lucid episodes reported by Alzheimer’s dementia (AD) and Lewy Body Dementias (LBD) caregivers. We analyzed survey data from 212 current AD ( n = 191) and LBD caregivers who reported the frequency, duration, and characteristics of 653 lucid episodes witnessed in the past month. Major Findings Most AD caregivers (67%) and LBD caregivers (81%) witnessed a lucid episode within the past month. LBD caregivers reported lucid episodes with greater changes in awareness and communication, compared to AD caregivers. LBD caregivers reported longer lucid episodes and that the PLWD knew about their change in lucidity, compared to AD caregivers. Conclusions Findings suggest that differences in lucid episode intensity, timing, and meta-awareness between AD and LBD are possible and may inform care strategies for PLWD.
In Response
Pai, Sher‐Lu , Harbell, Monica W. , Pai, Sher-Lu , Harbell, Monica W

Anesthesia & Analgesia | July 1, 2026 | Volume: 143 | Issue: 2 | Pages: e28-e29

10.1213/ane.0000000000008152 | PMID 42385731 Get It

Surgical Management of Non‐Allergic Rhinitis—An EAACI Task Force Position Paper
Lundberg, Marie , Waterschoot, Julie van , Moyaert, Mathilde, Chaker, Adam, Gevaert, Philippe , Hagemann, Jan , Hox, Valérie, Kleijwegt, Maarten, Klimek, Ludger , Lal, Devyani, Maza‐Solano, J. , Pfaar, Oliver, Ryser, Fabio S. , Silva, Diana, Toppila‐Salmi, Sanna , Wikstén, Johanna , Reitsma, Sietze, Gerven, Laura Van , van Waterschoot, Julie , Ryser, Fabio Simon , Shiappoli, Michele , Toppila-Salmi, Sanna , Wikstén, Johanna , Van Gerven, Laura , Hox, Valérie , Kleijwegt, Maarten C. , Lal, Devyani , Pfaar, Oliver , Reitsma, Sietze

Allergy | July 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/all.70424 | PMID 42385211 Get It

ABSTRACT Non‐allergic rhinitis is a frequent yet underdiagnosed cause of chronic nasal symptoms, including nasal congestion, rhinorrhoea, and upper airway hyperreactivity. Its pathophysiology involves neurogenic dysregulation, leading to excessive mucus production and vasodilation. While medical therapy remains first‐line, some patients experience persistent symptoms requiring surgical intervention. This review outlines key surgical options for refractory non‐allergic rhinitis: inferior turbinate (IT) reduction, vidian neurectomy, and posterior nasal nerve (PNN) ablation. IT reduction—performed using cold instruments, radiofrequency, laser, coblation, or microdebrider—remains the cornerstone treatment for nasal obstruction, offering durable symptom relief with low complication rates. Vidian neurectomy effectively reduces rhinorrhoea but carries risks of ocular dryness and transient facial numbness, limiting its indication to severe, refractory cases. PNN interventions, including cryotherapy, cold‐instrument techniques, and radiofrequency, provide a minimally invasive, outpatient alternative that selectively targets nasal parasympathetic and sensory fibers while sparing lacrimal innervation, yielding significant and lasting symptom improvement. Surgical management of non‐allergic rhinitis is effective and safe when tailored to symptom profile, anatomy, and prior medical treatment response. Advances in endoscopic and minimally invasive approaches have reduced complications, establishing these procedures as integral options in comprehensive non‐allergic rhinitis care.
Familial Aggregation of Parkinson Disease and Essential Tremor in Early and Late Onset Parkinson Disease Cohorts
Malfer, Lorenzo , Liu, Tina , Mullan, Aidan F. , Santoro, Emanuela , Lynott, Elena B. , Troxel, Colton E. , Derhab, Mohamed , Ghoniem, Khaled , Ross, Owen A. , Bower, James H. , Savica, Rodolfo , Mullan, Aidan , Ross, Owen A , Lynott, Elena , Troxel, Colton

Neurology | July 1, 2026 | Volume: 107 | Issue: 2 | Pages: No page available

10.1212/wnl.0000000000218315 | PMID 42385114 Get It

What is the Relevance of Neuron-Tumor Interactions in Malignant CNS Tumors?
Benarroch, Eduardo E. , Benarroch, Eduardo

Neurology | July 1, 2026 | Volume: 107 | Issue: 2 | Pages: No page available

10.1212/wnl.0000000000218291 | PMID 42385117 Get It

Fat-Free Mass Accretion: Limits, Targets, and Best Practices
Trexler, Eric T. , Torres, Marcella, Potter, Nicholas D., Ketterly, Jennifer, Kerkow-Provo, Zachary, Lane, Michael T., Jagim, Andrew R.

Strength & Conditioning Journal | July 1, 2026 | Volume: 48 | Issue: 4 | Pages: 521-539

10.1519/ssc.0000000000000986 Get It

ABSTRACT This review examines physiological limits, longitudinal projections, and best practices for muscle hypertrophy with a focus on bodybuilding and physique sport. Recurring body composition assessments using multicompartment models are recommended for monitoring short-term fat-free mass (FFM) changes and long-term muscular development. Normative data indicate that drug-free male athletes typically gain roughly 1.4 kg of FFM over 12 weeks of resistance training, with an interquartile range of 1–2 kg. A practical upper limit for FFM index in drug-free male athletes is approximately 28.5, although higher values have been observed in the context of elevated adiposity or anabolic androgenic steroid use. Female athletes tend to have roughly 70% less FFM at baseline but make proportionally similar FFM gains in response to resistance training. The present review models plausible short-term and long-term growth trajectories for both male and female lifters. Training practices that optimize hypertrophy include moderate loads (6–12 repetition maximum), training near muscular failure, and sufficient weekly volume (12–30 fractional sets per muscle group). Nutritional factors include maintaining modest caloric surpluses (0.1–0.25% body weight gain weekly), adequate protein intake (1.6–2.2 g/kg/d), sufficient carbohydrate intake (≥3 g/kg/d), and moderate fat intake (0.5–1.5 g/kg/d). Creatine and protein supplementation provide established hypertrophic benefits, while evidence for other supplements remains inconclusive.